FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155017029> ?p ?o ?g. }

• W2155017029 endingPage "964" @default.
• W2155017029 startingPage "960" @default.
• W2155017029 abstract "Pyrimethamine acts against malarial parasites by selectively inhibiting their dihydrofolate reductase-thymidylate synthase. Resistance to pyrimethamine in Plasmodium falciparum is due to point mutations in the DHFR domain, initially at residue 108 (S108N), with additional mutations imparting much greater resistance. Our previous work, the development of a simple rational drug design strategy to overcome such resistance, used suitable meta-substituents in the pyrimethamine framework to avoid the unfavorable steric clash with mutant side chains at position 108. Interestingly, the meta-chloro analog of pyrimethamine not only overcame the resistance due to S108N, but also that contributed by the more remote mutation, C59R. The present work improves on this by means of other meta-substituents. Against wild type DHFR, double mutant types A16V + S108T and C59R + S108T, and the highly pyrimethamine/cycloguanil-resistant quadruple-mutant form N51I + C59R + S108N + I164L, pyrimethamine itself gave Ki values of 1.5, 2.4, 72.3 and 859 nM, respectively. The meta-substituted analogs, especially the meta-bromo analog, were much more powerful inhibitors of these DHFRs, including the quadruple-mutant form (meta-bromo analog, Ki 5.1 nM). For comparison, the dihydropyrazine antifolate, WR99210, gave Ki values of 0.9, 3.2, 0.8 and 0.9 nM, respectively. Ki values were also measured against recombinant human DHFR, as were their activities against the growth of Plasmodium falciparum cultures bearing the double mutations (FCB and K1 strains) and quadruple mutation (V1/S) and the wild type (3D7). The meta-analogs were highly active against all of these, with the meta-bromo again being the strongest, having an IC50 of 37 nM against V1/S, compared to > 5000 nM for pyrimethamine itself and 1.1 nM for WR99210." @default.
• W2155017029 created "2016-06-24" @default.
• W2155017029 creator A5004160157 @default.
• W2155017029 creator A5037739252 @default.
• W2155017029 creator A5050539843 @default.
• W2155017029 creator A5055746584 @default.
• W2155017029 creator A5062941170 @default.
• W2155017029 creator A5067898061 @default.
• W2155017029 creator A5072469377 @default.
• W2155017029 creator A5087414292 @default.
• W2155017029 date "2003-02-25" @default.
• W2155017029 modified "2023-10-18" @default.
• W2155017029 title "Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites" @default.
• W2155017029 cites W1559242444 @default.
• W2155017029 cites W1964877775 @default.
• W2155017029 cites W1976416379 @default.
• W2155017029 cites W1985874427 @default.
• W2155017029 cites W1994911131 @default.
• W2155017029 cites W2004547182 @default.
• W2155017029 cites W2029812950 @default.
• W2155017029 cites W2031154281 @default.
• W2155017029 cites W2033911405 @default.
• W2155017029 cites W2034520962 @default.
• W2155017029 cites W2070514459 @default.
• W2155017029 cites W2079937435 @default.
• W2155017029 cites W2150657983 @default.
• W2155017029 cites W2320114424 @default.
• W2155017029 cites W2328289254 @default.
• W2155017029 cites W2332989592 @default.
• W2155017029 cites W2412319879 @default.
• W2155017029 cites W2415782258 @default.
• W2155017029 cites W2438909226 @default.
• W2155017029 cites W2525131337 @default.
• W2155017029 doi "https://doi.org/10.1039/b211636g" @default.
• W2155017029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12929634" @default.
• W2155017029 hasPublicationYear "2003" @default.
• W2155017029 type Work @default.
• W2155017029 sameAs 2155017029 @default.
• W2155017029 citedByCount "44" @default.
• W2155017029 countsByYear W21550170292012 @default.
• W2155017029 countsByYear W21550170292013 @default.
• W2155017029 countsByYear W21550170292014 @default.
• W2155017029 countsByYear W21550170292015 @default.
• W2155017029 countsByYear W21550170292016 @default.
• W2155017029 countsByYear W21550170292017 @default.
• W2155017029 countsByYear W21550170292018 @default.
• W2155017029 countsByYear W21550170292019 @default.
• W2155017029 countsByYear W21550170292020 @default.
• W2155017029 countsByYear W21550170292021 @default.
• W2155017029 countsByYear W21550170292022 @default.
• W2155017029 countsByYear W21550170292023 @default.
• W2155017029 crossrefType "journal-article" @default.
• W2155017029 hasAuthorship W2155017029A5004160157 @default.
• W2155017029 hasAuthorship W2155017029A5037739252 @default.
• W2155017029 hasAuthorship W2155017029A5050539843 @default.
• W2155017029 hasAuthorship W2155017029A5055746584 @default.
• W2155017029 hasAuthorship W2155017029A5062941170 @default.
• W2155017029 hasAuthorship W2155017029A5067898061 @default.
• W2155017029 hasAuthorship W2155017029A5072469377 @default.
• W2155017029 hasAuthorship W2155017029A5087414292 @default.
• W2155017029 hasConcept C104317684 @default.
• W2155017029 hasConcept C143065580 @default.
• W2155017029 hasConcept C176944494 @default.
• W2155017029 hasConcept C178790620 @default.
• W2155017029 hasConcept C181199279 @default.
• W2155017029 hasConcept C185592680 @default.
• W2155017029 hasConcept C203014093 @default.
• W2155017029 hasConcept C207583985 @default.
• W2155017029 hasConcept C2777035104 @default.
• W2155017029 hasConcept C2778048844 @default.
• W2155017029 hasConcept C2778371730 @default.
• W2155017029 hasConcept C2778397455 @default.
• W2155017029 hasConcept C2781320022 @default.
• W2155017029 hasConcept C2781382166 @default.
• W2155017029 hasConcept C29730261 @default.
• W2155017029 hasConcept C55493867 @default.
• W2155017029 hasConcept C71240020 @default.
• W2155017029 hasConcept C86803240 @default.
• W2155017029 hasConceptScore W2155017029C104317684 @default.
• W2155017029 hasConceptScore W2155017029C143065580 @default.
• W2155017029 hasConceptScore W2155017029C176944494 @default.
• W2155017029 hasConceptScore W2155017029C178790620 @default.
• W2155017029 hasConceptScore W2155017029C181199279 @default.
• W2155017029 hasConceptScore W2155017029C185592680 @default.
• W2155017029 hasConceptScore W2155017029C203014093 @default.
• W2155017029 hasConceptScore W2155017029C207583985 @default.
• W2155017029 hasConceptScore W2155017029C2777035104 @default.
• W2155017029 hasConceptScore W2155017029C2778048844 @default.
• W2155017029 hasConceptScore W2155017029C2778371730 @default.
• W2155017029 hasConceptScore W2155017029C2778397455 @default.
• W2155017029 hasConceptScore W2155017029C2781320022 @default.
• W2155017029 hasConceptScore W2155017029C2781382166 @default.
• W2155017029 hasConceptScore W2155017029C29730261 @default.
• W2155017029 hasConceptScore W2155017029C55493867 @default.
• W2155017029 hasConceptScore W2155017029C71240020 @default.
• W2155017029 hasConceptScore W2155017029C86803240 @default.
• W2155017029 hasIssue "6" @default.
• W2155017029 hasLocation W21550170291 @default.

• next